Copart Inc

CPRT is in a Stage 4 decline but qualifies for mean-reversion, so medium-term bias is tactically bullish. Price has bounced from extended oversold lows and is approaching the falling 9/20 EMA cluster without clear acceptance. Short-term timing is neutral; execution will be deferred until a pullback holds above the short EMAs, confirming support before entering.

• ↑Q3 revenue $1.24 B (+2.1% YoY); gross profit $572.6 M (+3.7%).
• ↑U.S. insurance ASP up 4.1% YoY offsets 2.4% unit decline.
• ↓U.S. insurance unit volumes -4.2% YoY signal weakening demand.